Viveve Medical Inc (VIVE)

Sector:
HEALTH CARE
Industry:
HEALTH CARE SUPPLIES
SIC:
ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS
CEO:
Scott C. Durbin
Employees:
70
345 INVERNESS DRIVE SOUTH, BUILDING B, SUITE 250, ENGLEWOOD, CO, 80112
4085301900

Viveve Medical, Inc. designs, develops, manufactures, and markets medical devices for the non-invasive treatment of vaginal introital laxity, sexual function, vaginal rejuvenation, and stress urinary incontinence. Viveve System comprises of the radiofrequency generator, reusable handpiece, and treatment tip.

Data derived from most recent annual or quarterly report
Market Cap 2.359 Million Shares Outstanding10.724 Million Avg 30-day Volume 691.27 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-0.59
Price to Revenue1.0683 Debt to Equity4.7534 EBITDA-20.199 Million
Price to Book Value6.159 Operating Margin-309.72749999999996 Enterprise Value7.013 Million
Current Ratio0.886 EPS Growth-0.119 Quick Ratio0.624
1 Yr BETA 0.4527 52-week High/Low 1.24 / 0.22 Profit Margin-336.7858
Operating Cash Flow Growth-35.844 Free Cash Flow to Firm (FCFF) TTM -13.685 Million Free Cash Flow to Equity (FCFE) TTM-15.394 Million
Altman Z-Score-34.6379

Are you looking for this stock instead?

View SEC Filings from VIVE instead.

View recent insider trading info

Viveve Medical Inc YCharts
Yahoo! Finance finviz
SEC Web Site SEC DEF 14A Filings

Funds Holding VIVE (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding VIVE

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Financial Reporting

Ownership

  • 4: filed on 2023-01-05 by BASTA STEVEN L
  • 4: filed on 2023-01-05 by DURBIN SCOTT
  • 4: filed on 2023-01-05 by JORN DEBORA
  • 4: filed on 2023-01-05 by MORRIS ARLENE
  • 4: filed on 2023-01-05 by PRESNELL SHARON COLLINS
  • 4: filed on 2023-01-05 by ROBBINS JIM B
  • 4: filed on 2022-01-06 by JORN DEBORA
  • 4: filed on 2022-01-06 by MORRIS ARLENE
  • 4: filed on 2022-01-06 by PRESNELL SHARON COLLINS
  • 4: filed on 2022-01-06 by ROBBINS JIM B

    • Events (8k)

  • 8-K: filed on 2023-01-18:
    Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
  • 8-K: filed on 2023-01-17:
    Item 2.05: Cost Associated with Exit or Disposal Activities
    Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-12-15:
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-12-02:
    Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
  • 8-K: filed on 2022-12-01:
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-11-23:
    Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
  • 8-K: filed on 2022-11-10:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-10-04:
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-09-27:
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-09-22:
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits

    • Proposed Sales (Form 144)

    Proxy

    Prospectus

    All

    Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    none

    Open Market Sells (S)

    none

    Exercise Derivative Conversion (M)

    none

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    MORRIS ARLENE

    • Director
    		 36,000 2023-01-03 1

    ROBBINS JIM B SVP, FINANCE & ADMINISTRATION

    • Officer
    		 57,000 2023-01-03 1

    BASTA STEVEN L

    • Director
    		 72,000 2023-01-03 1

    DURBIN SCOTT CHIEF EXECUTIVE OFFICER

    • Officer
    • Director
    		 360,000 2023-01-03 1

    PRESNELL SHARON COLLINS

    • Director
    		 36,000 2023-01-03 1

    JORN DEBORA

    • Director
    		 36,000 2023-01-03 1

    ZADEREJ KAREN L.

    • Director
    		 0 2019-11-26 0

    GOLDMAN SACHS GROUP INC

    GOLDMAN SACHS & CO. LLC

    • 10% Owner
    		 0 2019-09-30 0

    NANTAHALA CAPITAL MANAGEMENT, LLC

    • 10% Owner
    		 6,581,465 2019-04-25 0

    NANTAHALA CAPITAL MANAGEMENT, LLC

    HARKEY WILMOT B.

    MACK DANIEL

    • 10% Owner
    		 6,581,465 2019-04-25 0

    ATKINSON JAMES G. CBO & PRESIDENT

    • Officer
    		 964,606 2019-01-29 0

    JANNEY DANIEL

    • Director
    		 1,442,534 2018-12-31 0

    PLEXICO JON M

    • 10% Owner
    		 3,872,259 2018-10-01 0

    BUSH LORI H

    • Director
    		 No longer subject to file 2018-07-02 0

    SCHELLER PATRICIA CHIEF EXECUTIVE OFFICER

    • Officer
    • Director
    		 0 2018-01-23 0

    STONEPINE CAPITAL MANAGEMENT, LLC

    STONEPINE CAPITAL, L.P.

    PLEXICO JON M

    LYNCH TIMOTHY P

    • Director
    • 10% Owner
    		 3,849,711 2017-03-17 0

    SMITH BRIGITTE

    • Director
    		 No longer subject to file 2016-09-30 0

    SIMPSON CARL

    • Director
    		 172,195 2015-12-16 0

    COLELLA MARK SAMUEL

    • Director
    • 10% Owner
    		 7,753,678 2015-12-16 0

    STONEPINE CAPITAL, L.P.

    • 10% Owner
    		 18,397,682 2015-11-24 0

    ALTA BIOEQUITIES MANAGEMENT, LLC

    ALTA BIOEQUITIES, L.P.

    • 10% Owner
    		 5,455,632 2015-11-24 0

    5AM PARTNERS II, LLC

    5AM VENTURES II LP

    5AM CO-INVESTORS II LP

    SCHWAB ANDREW J.

    DIEKMAN JOHN D

    ROCKLAGE SCOTT M

    • 10% Owner
    		 7,598,678 2015-05-14 0

    ALTA BIOEQUITIES MANAGEMENT, LLC

    JANNEY DANIEL

    ALTA BIOEQUITIES, L.P.

    • Director
    • 10% Owner
    		 1,895,788 2014-09-23 0

    GBS VENTURE PARTNERS PTY, LTD

    GBS BIOVENTURES III A/C

    • 10% Owner
    		 7,197,614 2014-09-23 0

    PENDERGAST EDWARD H

    • Director
    		 0 2011-04-08 0

    DUNN KEVIN J

    • Director
    		 0 2011-04-08 0

    NORTON H B BRENT

    • Director
    		 0 2011-04-08 0

    TAUSCHER MARK R PRESIDENT AND CEO

    • Officer
    • Director
    		 0 2011-04-08 0

    HOLMES BENJAMIN L

    • Director
    		 0 2011-04-08 0

    BRENNER LOUIS MD

    • Director
    		 0 2009-06-04 0

    RUDKO ROBERT I CHIEF SCIENTIFIC OFFICER

    • Officer
    • Director
    		 0 2009-06-03 0

    THOMASCH JAMES G SENIOR VICE PRESIDENT & CFO

    • Officer
    		 0 2009-06-03 0

    MAGAZINE ALAN H

    • Director
    		 No longer subject to file 2009-06-03 0

    LUPPI KENNETH J VP, OPERATIONS

    • Officer
    		 0 2009-06-03 0

    PUGLISI VINCENT MANAGING DIR - INTERNATIONAL

    • Officer
    		 0 2009-06-03 0

    KAYNE FRED

    • SHAREHOLDER
    		 1,063,300 2008-12-09 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed    		 Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
    No current insider transactions

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available
    VIVEVE MEDICAL INC VIVE 2023-11-28 22:15:04 UTC -68.8182 74.1382 250000
    VIVEVE MEDICAL INC VIVE 2023-11-28 21:45:03 UTC -68.8182 74.1382 250000
    VIVEVE MEDICAL INC VIVE 2023-11-28 21:15:04 UTC -68.8182 74.1382 250000
    VIVEVE MEDICAL INC VIVE 2023-11-28 20:45:04 UTC -68.8182 74.1382 250000
    VIVEVE MEDICAL INC VIVE 2023-11-28 20:15:04 UTC -68.8182 74.1382 250000
    VIVEVE MEDICAL INC VIVE 2023-11-28 19:45:03 UTC -68.8182 74.1382 250000
    VIVEVE MEDICAL INC VIVE 2023-11-28 19:15:04 UTC -68.8182 74.1382 250000
    VIVEVE MEDICAL INC VIVE 2023-11-28 18:45:03 UTC -68.8182 74.1382 250000
    VIVEVE MEDICAL INC VIVE 2023-11-28 18:15:03 UTC -68.8182 74.1382 250000
    VIVEVE MEDICAL INC VIVE 2023-11-28 17:45:04 UTC -68.8182 74.1382 250000
    VIVEVE MEDICAL INC VIVE 2023-11-28 17:15:04 UTC -68.8182 74.1382 250000
    VIVEVE MEDICAL INC VIVE 2023-11-28 16:45:04 UTC -68.8182 74.1382 250000
    VIVEVE MEDICAL INC VIVE 2023-11-28 16:15:04 UTC -68.8182 74.1382 250000
    VIVEVE MEDICAL INC VIVE 2023-11-28 15:45:03 UTC -68.8182 74.1382 250000
    VIVEVE MEDICAL INC VIVE 2023-11-28 15:15:03 UTC -68.8182 74.1382 250000
    VIVEVE MEDICAL INC VIVE 2023-11-28 14:45:04 UTC -68.8182 74.1382 250000
    VIVEVE MEDICAL INC VIVE 2023-11-28 14:15:04 UTC -68.8182 74.1382 250000
    VIVEVE MEDICAL INC VIVE 2023-11-28 13:45:04 UTC -68.8182 74.1382 200000
    VIVEVE MEDICAL INC VIVE 2023-11-28 13:15:03 UTC -68.8182 74.1382 200000
    VIVEVE MEDICAL INC VIVE 2023-11-28 12:45:04 UTC -68.8182 74.1382 200000

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin

    No recent transactions

    *** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

    WhaleWisdom Logo

    Elevate your investments